Music Licensing, Inc. Reports Strong Fiscal Year 2023 Results 26-02-2024, 21:47

Teva Presents New Phase 3 Efficacy, Safety and Tolerability Data from SOLARIS Trial Evaluating TEV-‘749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable for Adult Patients Diagnosed with Schizophrenia 21-09-2024, 15:15

Corporate Bookers Race to Secure a Gold Coast Venue as 13-02-2023, 06:01